Biodistribution and toxicological evaluation of micron- and nano-sized erythrocyte-derived optical particles in healthy Swiss Webster mice

Raviraj Vankayala, Jenny T. Mac, Joshua M. Burns, Eugene Dunn, Stefanie Carroll, Edver M. Bahena, Dipti K. Patel, Stephen Griffey, Bahman Anvari

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Particle-based systems provide a capability for the delivery of imaging and/or therapeutic payloads. We have engineered constructs derived from erythrocytes, and doped with the FDA-approved near infrared dye, indocyanine green (ICG). We refer to these optical particles as NIR erythrocyte-mimicking transducers (NETs). A particular feature of NETs is that their diameters can be tuned from micron- to nano-scale. Herein, we investigated the effects of micron- (≈2.6 μm diameter), and nano- (≈145 nm diameter) sized NETs on their biodistribution, and evaluated their acute toxicity in healthy Swiss Webster mice. Following tail vein injection of free ICG and NETs, animals were euthanized at various time points up to 48 hours. Fluorescence analysis of blood showed that nearly 11% of the injected amount of nano-sized NETs (nNETs) remained in blood at 48 hours post-injection as compared to ≈5% for micron-sized NETs (μNETs). Similarly, at this time point, higher levels of nNETs were present in various organs including the lungs, liver, and spleen. Histological analyses of various organs, extracted at 24 hours post-injection of NETs, did not show pathological alterations. Serum biochemistry profiles, in general, did not show elevated levels of the various analyzed biomarkers associated with liver and kidney functions. Values of various hematological profiles remained within the normal ranges following the administration of μNETs and nNETs. Results of this study suggest that erythrocyte-derived particles can potentially provide a non-toxic platform for delivery of ICG.

Original languageEnglish (US)
Pages (from-to)2123-2133
Number of pages11
JournalBiomaterials Science
Volume7
Issue number5
DOIs
StatePublished - May 2019

Fingerprint

Transducers
Indocyanine Green
Liver
Blood
Biochemistry
Biomarkers
Toxicity
Animals
Coloring Agents
Dyes
Fluorescence
Infrared radiation
Imaging techniques

ASJC Scopus subject areas

  • Biomedical Engineering
  • Materials Science(all)

Cite this

Biodistribution and toxicological evaluation of micron- and nano-sized erythrocyte-derived optical particles in healthy Swiss Webster mice. / Vankayala, Raviraj; Mac, Jenny T.; Burns, Joshua M.; Dunn, Eugene; Carroll, Stefanie; Bahena, Edver M.; Patel, Dipti K.; Griffey, Stephen; Anvari, Bahman.

In: Biomaterials Science, Vol. 7, No. 5, 05.2019, p. 2123-2133.

Research output: Contribution to journalArticle

Vankayala, Raviraj ; Mac, Jenny T. ; Burns, Joshua M. ; Dunn, Eugene ; Carroll, Stefanie ; Bahena, Edver M. ; Patel, Dipti K. ; Griffey, Stephen ; Anvari, Bahman. / Biodistribution and toxicological evaluation of micron- and nano-sized erythrocyte-derived optical particles in healthy Swiss Webster mice. In: Biomaterials Science. 2019 ; Vol. 7, No. 5. pp. 2123-2133.
@article{77af8cbd24ce49e7b06477fd475b79d2,
title = "Biodistribution and toxicological evaluation of micron- and nano-sized erythrocyte-derived optical particles in healthy Swiss Webster mice",
abstract = "Particle-based systems provide a capability for the delivery of imaging and/or therapeutic payloads. We have engineered constructs derived from erythrocytes, and doped with the FDA-approved near infrared dye, indocyanine green (ICG). We refer to these optical particles as NIR erythrocyte-mimicking transducers (NETs). A particular feature of NETs is that their diameters can be tuned from micron- to nano-scale. Herein, we investigated the effects of micron- (≈2.6 μm diameter), and nano- (≈145 nm diameter) sized NETs on their biodistribution, and evaluated their acute toxicity in healthy Swiss Webster mice. Following tail vein injection of free ICG and NETs, animals were euthanized at various time points up to 48 hours. Fluorescence analysis of blood showed that nearly 11{\%} of the injected amount of nano-sized NETs (nNETs) remained in blood at 48 hours post-injection as compared to ≈5{\%} for micron-sized NETs (μNETs). Similarly, at this time point, higher levels of nNETs were present in various organs including the lungs, liver, and spleen. Histological analyses of various organs, extracted at 24 hours post-injection of NETs, did not show pathological alterations. Serum biochemistry profiles, in general, did not show elevated levels of the various analyzed biomarkers associated with liver and kidney functions. Values of various hematological profiles remained within the normal ranges following the administration of μNETs and nNETs. Results of this study suggest that erythrocyte-derived particles can potentially provide a non-toxic platform for delivery of ICG.",
author = "Raviraj Vankayala and Mac, {Jenny T.} and Burns, {Joshua M.} and Eugene Dunn and Stefanie Carroll and Bahena, {Edver M.} and Patel, {Dipti K.} and Stephen Griffey and Bahman Anvari",
year = "2019",
month = "5",
doi = "10.1039/c8bm01448e",
language = "English (US)",
volume = "7",
pages = "2123--2133",
journal = "Biomaterials Science",
issn = "2047-4830",
publisher = "Royal Society of Chemistry",
number = "5",

}

TY - JOUR

T1 - Biodistribution and toxicological evaluation of micron- and nano-sized erythrocyte-derived optical particles in healthy Swiss Webster mice

AU - Vankayala, Raviraj

AU - Mac, Jenny T.

AU - Burns, Joshua M.

AU - Dunn, Eugene

AU - Carroll, Stefanie

AU - Bahena, Edver M.

AU - Patel, Dipti K.

AU - Griffey, Stephen

AU - Anvari, Bahman

PY - 2019/5

Y1 - 2019/5

N2 - Particle-based systems provide a capability for the delivery of imaging and/or therapeutic payloads. We have engineered constructs derived from erythrocytes, and doped with the FDA-approved near infrared dye, indocyanine green (ICG). We refer to these optical particles as NIR erythrocyte-mimicking transducers (NETs). A particular feature of NETs is that their diameters can be tuned from micron- to nano-scale. Herein, we investigated the effects of micron- (≈2.6 μm diameter), and nano- (≈145 nm diameter) sized NETs on their biodistribution, and evaluated their acute toxicity in healthy Swiss Webster mice. Following tail vein injection of free ICG and NETs, animals were euthanized at various time points up to 48 hours. Fluorescence analysis of blood showed that nearly 11% of the injected amount of nano-sized NETs (nNETs) remained in blood at 48 hours post-injection as compared to ≈5% for micron-sized NETs (μNETs). Similarly, at this time point, higher levels of nNETs were present in various organs including the lungs, liver, and spleen. Histological analyses of various organs, extracted at 24 hours post-injection of NETs, did not show pathological alterations. Serum biochemistry profiles, in general, did not show elevated levels of the various analyzed biomarkers associated with liver and kidney functions. Values of various hematological profiles remained within the normal ranges following the administration of μNETs and nNETs. Results of this study suggest that erythrocyte-derived particles can potentially provide a non-toxic platform for delivery of ICG.

AB - Particle-based systems provide a capability for the delivery of imaging and/or therapeutic payloads. We have engineered constructs derived from erythrocytes, and doped with the FDA-approved near infrared dye, indocyanine green (ICG). We refer to these optical particles as NIR erythrocyte-mimicking transducers (NETs). A particular feature of NETs is that their diameters can be tuned from micron- to nano-scale. Herein, we investigated the effects of micron- (≈2.6 μm diameter), and nano- (≈145 nm diameter) sized NETs on their biodistribution, and evaluated their acute toxicity in healthy Swiss Webster mice. Following tail vein injection of free ICG and NETs, animals were euthanized at various time points up to 48 hours. Fluorescence analysis of blood showed that nearly 11% of the injected amount of nano-sized NETs (nNETs) remained in blood at 48 hours post-injection as compared to ≈5% for micron-sized NETs (μNETs). Similarly, at this time point, higher levels of nNETs were present in various organs including the lungs, liver, and spleen. Histological analyses of various organs, extracted at 24 hours post-injection of NETs, did not show pathological alterations. Serum biochemistry profiles, in general, did not show elevated levels of the various analyzed biomarkers associated with liver and kidney functions. Values of various hematological profiles remained within the normal ranges following the administration of μNETs and nNETs. Results of this study suggest that erythrocyte-derived particles can potentially provide a non-toxic platform for delivery of ICG.

UR - http://www.scopus.com/inward/record.url?scp=85064914913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064914913&partnerID=8YFLogxK

U2 - 10.1039/c8bm01448e

DO - 10.1039/c8bm01448e

M3 - Article

C2 - 30869663

AN - SCOPUS:85064914913

VL - 7

SP - 2123

EP - 2133

JO - Biomaterials Science

JF - Biomaterials Science

SN - 2047-4830

IS - 5

ER -